🔗 Share this article

An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed fat-burning properties. Followers are urged to contact these profiles privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Voice Worries

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in individuals injecting substances of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still breach pharmaceutical, advertising, and consumer laws, potentially leading to penalties, legal action or prison.

Platform Response and Material Elimination

According to the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in strengthening enforcement strategies.

Online Marketplace Operations

Research also discovered communities with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, filled with photos of slimming results, positive testimonials and step-by-step guides for preparing or injecting at home.

After minutes of joining one community, a vendor shared contact information, where most transactions take place. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the substance was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about weight, health issues or past usage.

Product Information and Pricing

Inside these communities, posts display black plastic parcels with postal service labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Actions

A spokesperson for Telegram stated it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they can’t verify. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.

Her team has already seen patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a company investigational substance not yet authorized … may expose users to potentially significant medical dangers”.